论文部分内容阅读
目的:探讨奥扎格雷钠治疗急性脑梗死的临床疗效。方法:将我院2009年1月～2011年12月间收治的114例急性脑梗死患者随机分为观察组(n=57)和对照组(n=57),两组患者入院后均给予常规治疗,观察组患者在此基础上加用奥扎格雷钠,观察两组患者的临床疗效和不良反应。结果:观察组的治疗总有效率为96.5%,对照组的的治疗总有效率为78.9%,组间差异有统计学意义(P<0.05)。观察组与对照组的不良反应发生率差异无统计学意义(P>0.05)。结论:采用奥扎格雷钠治疗急性脑梗死的临床治疗效果良好,且不良反应发生率较低,对改善患者神经功能缺损具有重要的意义。
Objective: To investigate the clinical efficacy of ozagrel sodium in the treatment of acute cerebral infarction. Methods: A total of 114 acute cerebral infarction patients admitted from January 2009 to December 2011 in our hospital were randomly divided into observation group (n = 57) and control group (n = 57). Both groups were given conventional The patients in the observation group and the observation group were given sodium ozagrel on this basis to observe the clinical efficacy and adverse reactions of the two groups. Results: The total effective rate of the observation group was 96.5%, while that of the control group was 78.9%. The difference between the two groups was statistically significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P> 0.05). Conclusion: Ozagrel sodium in the treatment of acute cerebral infarction with good clinical outcomes, and a low incidence of adverse reactions, to improve the patient’s neurological deficit is of great significance.